Dr. Peter J. Pitt
President, Center for Medicine in the Public Interest
Chief Regulatory Officer, Adherent Health Strategies
Executive Partner, Your Encore
Former Associate Commissioner, US Food and Drug Administration

Dr. Peter Pitts is President of the Center for Medicine in the Public Interest. A former member of the United States Senior Executive Service, Dr. Peter was FDA’s Associate Commissioner for External Relations, serving as senior communications and policy adviser to the Commissioner. He supervised FDA's Office of Public Affairs, Office of the Ombudsman, Office of Special Health Issues, Office of Executive Secretariat, and Advisory Committee Oversight and Management.  He served on the agency’s obesity working group and counterfeit drug taskforce and as a Special Government Employee (SGE) consultant to the FDA’s Risk Communications Advisory Committee.  Specific areas of global policy expertise include FDA policy and process, healthcare technology assessment and reimbursement issues, social media and off label-communications, biosimilar development, Rx-to-OTC switching, risk management plans, GMP policies, pharmacy education programs, drug safety, DTC/ItP, Critical Path, personalized medicine, clinical trial transparency, IP protection, FDA reform, drug importation, counterfeiting, genetically modified food issues, food safety and security, recalls, nutritional labeling.

In 2010, he was named by Modern Healthcare magazine as one of the 300 “most powerful people in American healthcare.”